Primary study · included by 1 review
O'Sullivan and Thibodeau 1996
ProbableThe reviews cited this study without a PMID, DOI or NCT, so it is matched by first author and year. Two different studies by the same author in the same year could be merged here.
Trial PICO
Not extracted yet. Trial-level population, intervention, comparator, outcomes and design will appear here after the trial extraction run. Until then, the reviews below describe the study.
Results
Not extracted yet. Per-trial results (events, means, effect and weight as each review's forest plot reports them) will appear here after the trial extraction run.
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Development of any (cavitated or non-cavitated) carious lesion Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 6 months to 3.5 years | OR 4.13 [3.33, 5.12] | 12 studies · 3010 participants | Moderate |
Development of any (cavitated or non-cavitated) carious lesion Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 6 months to 3.5 years | OR 5.16 [2.99, 8.91] | 5 studies · 736 participants | Ungraded |
Development of any (cavitated or non-cavitated) carious lesion Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 6 months to 3.5 years | OR 3.92 [3.20, 4.80] | 9 studies · 2577 participants | Ungraded |
Development of any (cavitated or non-cavitated) carious lesion Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 1 year | OR 4.37 [3.50, 5.45] | 4 studies · 2016 participants | Ungraded |
Development of any (cavitated or non-cavitated) carious lesion Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 2.7 years (31 months median) | OR 33.00 [3.18, 342.26] | 1 study · 28 participants | Ungraded |
Development of any (cavitated or non-cavitated) carious lesion Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 2 years | OR 2.53 [1.22, 5.23] | 4 studies · 297 participants | Ungraded |
Development of any (cavitated or non-cavitated) carious lesion Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 6 months to 3.5 years | OR 3.82 [2.01, 7.26] | 6 studies · 732 participants | Ungraded |
Development of any (cavitated or non-cavitated) carious lesion Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 3.5 years (42 months) | OR 4.23 [2.49, 7.18] | 1 study · 366 participants | Ungraded |
Development of any (cavitated or non-cavitated) carious lesion Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 6 months | OR 4.65 [2.01, 10.76] | 2 studies · 303 participants | Ungraded |
Development of any (cavitated or non-cavitated) carious lesion Mutans streptococci present in oral samples at baseline vs Mutans streptococci absent in oral samples at baseline · 6 months to 3.5 years | OR 4.36 [3.53, 5.39] | 6 studies · 2278 participants | Ungraded |
1 including review in total.